4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000105
Chief Medical Officer sold 1,707 shares at $28.36 ($48,411)
- Chief Medical Officer acquired 5,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,750 | 25,866 | D | ||
| 2023-06-30 | Sale : show line 2 in the form 10b5-1 | −1,707 | $28.36 | $48,411 | 24,159 | D |
| Open-market sales · 1,707 sh · avg $28.36 · $48,411 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-06-28 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −5,750 | 5,750 | D |
Loading xslF345X04/wk-form4_1688155583.xml…